Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

Nasopharyngeal pneumococcal carriage rates among HIV-infected adults following widespread pediatric use of conjugate pneumococcal vaccine-13.

Feola TD, Bonville CA, Cibula DA, Jose S, Nattanmai G, Domachowske JB, Suryadevara M.

Hum Vaccin Immunother. 2016 Sep;12(9):2441-6. doi: 10.1080/21645515.2016.1172758. Epub 2016 May 24.

2.

Invasive Pneumococcal Disease Following the Introduction of 13-Valent Conjugate Vaccine in Children in New York City From 2007 to 2012.

Farnham AC, Zimmerman CM, Papadouka V, Konty KJ, Zucker JR, Nattanmai GV, Jose S, Rosen JB.

JAMA Pediatr. 2015 Jul;169(7):646-52. doi: 10.1001/jamapediatrics.2015.0612.

PMID:
25938798
3.

Characterization of methicillin-resistant Staphylococcus aureus isolates collected in 2005 and 2006 from patients with invasive disease: a population-based analysis.

Limbago B, Fosheim GE, Schoonover V, Crane CE, Nadle J, Petit S, Heltzel D, Ray SM, Harrison LH, Lynfield R, Dumyati G, Townes JM, Schaffner W, Mu Y, Fridkin SK; Active Bacterial Core surveillance MRSA Investigators.

J Clin Microbiol. 2009 May;47(5):1344-51. doi: 10.1128/JCM.02264-08. Epub 2009 Mar 25.

Supplemental Content

Loading ...
Support Center